Within the Types dimension, the market differentiates into distinct service models that together shape the competitive topology. Cognitive‑behavioral therapy for insomnia (CBT‑I) remains the cornerstone, delivering evidence‑based, therapist‑led programs that dominate the non‑drug segment. Pharmacologic therapy encompasses prescription hypnotics and emerging orexin‑receptor antagonists, contributing a sizable share of revenue despite regulatory scrutiny. Device‑based therapy—including CPAP, BiPAP, and mandibular advancement devices—addresses obstructive sleep apnea and represents the most capital‑intensive category. Telehealth platforms have accelerated adoption by offering remote assessment, monitoring, and follow‑up, thereby expanding geographic reach and reducing overhead. Finally, integrated wellness programs combine sleep coaching with nutrition, stress management, and physical activity, targeting the growing consumer‑driven market for holistic health. Each type adds a unique value proposition, influencing overall market growth, pricing dynamics, and investment priorities across the Sleep Therapy Services sector.